Anders Pommer Vallentin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cardiovascular Disease

Squamous Cell Carcinoma

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms - a Danish population-based case-control study. Blood advances (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study. Blood advances 8 (16) (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study. Blood advances 8 (16) (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec C El-Galaly, Anne Stidsholt Roug
Use of statins and risk of myeloproliferative neoplasms - a Danish nationwide case-control study. Blood advances (2023)